The Impact of First Year Clinical Variables of Heart Transplant Recipients on Ten-Year Survival

Objective: Heart transplantation (HTx) is the treatment of choice for patients with end-stage heart failure. It is important to determine the factors related to long-term mortality at HTx. We aim to evaluate the effect of the first year clinical variables on 10-year survival at HTx. Methods: The data of 76 consecutive adult HTx recipients who survived more than 1 year after transplantation between April 1998 and July 2007 in a tertiary medical center were retrospectively evaluated. The survival status was checked for each patient at December 2018. We analyzed the effect of renal function through creatinine levels, average resting heart rate, acute rejection episodes, infections, and left ventricular ejection fraction (LVEF) within the first year after HTx on survival. Results: The mean age was 41 6 12 years. Percentage of male was 84%. Median survival was 145 6 32months (95% CI, 80.72-209.27), and 36 out of 76 (47.3%) patients died during follow-up. LVEF was found lowered in nonsurvived group compared to survived ones [57.2 6 5.8% vs 59.3 6 2.1% (P ¼ .043)]. Cox regression analyses revealed that only LVEF and creatinine at the end of the first year after HTx were found to be significantly associated with mortality [(HR ¼ 0.91, 95% CI, 0.85-0.98, P ¼ .012) and (HR ¼ 1.09, 95% CI, 1.68-5.67, P < .001), respectively]. Conclusion: Decrease in LVEF and high serum creatinine level at the end of the first year after HTx were found to be associated with poor 10-year survival in HTx recipients.

PDF

___

1. Mangini S, Alves BR, Silvestre OM, et al. Heart transplantation: Review. Einstein (Sao Paulo). 2015;13(2):310-318. [CrossRef]
2. Tonsho M, Michel S, Ahmed Z, Alessandrini A, Madsen JC. Heart transplantation: Challenges facing the field. Cold Spring Harb Perspect Med. 2014;4(5):a015636. [CrossRef]
3. Jung SH, Kim JJ, Choo SJ, Yun TJ, Chung CH, Lee JW. Long-term mortality in adult orthotopic heart transplant recipients. J Korean Med Sci. 2011;26(5):599-603. [CrossRef]
4. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant. 2005;24(11):1710-1720. [CrossRef]
5. Ingvarsson A, Werther Evaldsson A, Waktare J, et al. Normal reference ranges for transthoracic echocardiography following heart transplantation. J Am Soc Echocardiogr. 2018;31(3):349-360. [CrossRef]
6. Antunes MJ, Biernat M, Sola E, et al. Cardiac allograft systolic function. Is the aetiology (ischaemic or idiopathic) a determinant of ventricular function in the heart transplant patient? Interact Cardiovasc Thorac Surg. 2008;7(4):586-590; discussion 90. [Cross- Ref]
7. Barbir M, Lazem F, Banner N, Mitchell A, Yacoub M. The prognostic significance of non-invasive cardiac tests in heart transplant recipients. Eur Heart J. 1997;18(4):692-696. [CrossRef]
8. Vakil K, Taimeh Z, Sharma A, et al. Incidence, predictors, and temporal trends of sudden cardiac death after heart transplantation. Heart Rhythm. 2014;11(10):1684-1690. [CrossRef]
9. Clemmensen TS, Eiskjaer H, Logstrup BB, Ilkjaer LB, Poulsen SH. Left ventricular global longitudinal strain predicts major adverse cardiac events and all-cause mortality in heart transplant patients. J Heart Lung Transplant. 2017;36(5):567-576. [CrossRef]
10. Sarvari SI, Gjesdal O, Gude E, et al. Early postoperative left ventricular function by echocardiographic strain is a predictor of 1-year mortality in heart transplant recipients. J Am Soc Echocardiogr. 2012;25(9):1007-1014. [CrossRef]
11. Kobayashi Y, Kobayashi Y, Yang HM, et al. Long-term prognostic value of invasive and non-invasive measures early after heart transplantation. Int J Cardiol. 2018;260:31-35. [CrossRef]
12. Potter E, Marwick TH. Assessment of left ventricular function by echocardiography: The case for routinely adding global longitudinal strain to ejection fraction. JACC Cardiovasc Imaging. 2018;11(2 Pt 1):260-274. [CrossRef]
13. Lund LH, Khush KK, Cherikh WS, et al. The registry of the international society for heart and lung transplantation: Thirty-fourth adult heart transplantation report-2017; focus theme: Allograft ischemic time. J Heart Lung Transplant. 2017;36(10):1037-1046. [CrossRef]
14. Jokinen JJ, Tikkanen J, Kukkonen S, et al. Natural course and risk factors for impaired renal function during the first year after heart transplantation. J Heart Lung Transplant. 2010;29(6):633-640. [CrossRef]
15. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med. 2003;349(10):931-940. [CrossRef]
16. Janus N, Launay-Vacher V, Sebbag L, et al. Renal insufficiency, mortality, and drug management in heart transplant. Results of the CARIN study. Transpl Int. 2014;27(9):931-938. [CrossRef]
17. Al Aly Z, Abbas S, Moore E, Diallo O, Hauptman PJ, Bastani B. The natural history of renal function following orthotopic heart transplant. Clin Transplant. 2005;19(5):683-689. [CrossRef]
18. Puttarajappa CM, Bernardo JF, Kellum JA. Renal complications following lung transplantation and heart transplantation. Crit Care Clin. 2019;35(1):61-73. [CrossRef]
19. Kolsrud O, Karason K, Holmberg E, et al. Renal function and outcome after heart transplantation. J Thorac Cardiovasc Surg. 2018;155(4):1593-1604e1. [CrossRef]
20. Arora S, Andreassen A, Simonsen S, et al. Prognostic importance of renal function 1 year after heart transplantation for all-cause and cardiac mortality and development of allograft vasculopathy. Transplantation. 2007;84(2):149-154. [CrossRef]
21. Navarro-Manchon J, Martinez-Dolz L, Almenar L, et al. Prognostic value of glomerular filtration rate 1 year after heart transplantation. Rev Esp Cardiol. 2010;63(5):564-570. [CrossRef]
22. Navarro-Manchon J, Almenar Bonet L, Martinez-Dolz L, et al. Mortality from renal dysfunction in heart transplant patients: Creatinine versus glomerular filtration rate. Transplant Proc. 2010;42(8):3196-3198. [CrossRef]
23. Gonzalez-Vilchez F, Arizon JM, Segovia J, et al. Chronic renal dysfunction in maintenance heart transplant patients: The ICEBERG study. Transplant Proc. 2014;46(1):14-20. [CrossRef]
24. Grupper A, Gewirtz H, Kushwaha S. Reinnervation post-heart transplantation. Eur Heart J. 2018;39(20):1799-1806. [CrossRef]
25. Liebo M, Newman J, Joshi A, et al. Elevated heart rate following heart transplantation is associated with increased graft vasculopathy and mortality. J Card Fail. 2019;25(4):249-256. [CrossRef]
26. Castel MA, Roig E, Rios J, et al. Long-term prognostic value of elevated heart rate one year after heart transplantation. Int J Cardiol. 2013;168(3):2003-2007. [CrossRef]
27. Melero-Ferrer JL, Sanchez-Lazaro IJ, Almenar-Bonet L, et al. Impact of basal heart rate on long-term prognosis of heart transplant patients. Transpl Int. 2013;26(5):502-507. [CrossRef]
28. Anand RG, Reddy MT, Yau CL, et al. Usefulness of heart rate as an independent predictor for survival after heart transplantation. Am J Cardiol. 2009;103(9):1290-1294. [CrossRef]
29. Shah AB, Patel JK, Rafiei M, Morrissey RP, Kittleson MM, Kobashigawa JA. The impact of mean first-year heart rate on outcomes after heart transplantation: Does it make a difference? Clin Transplant. 2013;27(5):659-665. [CrossRef]
30. Ciarka A, Lund LH, Van Cleemput J, Voros G, Droogne W, Vanhaecke J. Effect of heart rate and use of beta blockers onmortality after heart transplantation. AmJ Cardiol. 2016;118(12):1916-1921. [CrossRef]